Letter · 2015

Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter

John C. Ashton

Cancer Research, 75(11), 2400 · Published 14 May 2015 · DOI 10.1158/0008-5472.can-14-3763

View at the publisherCite this paper

In brief

“Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter” is a 2015 letter by John C. Ashton, published in Cancer Research. OpenAlex counts 176 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
176
Most cited in
2021 (23)
References
6
Authors
1

Abstract

Advances in the theory of combination therapy ([1][1]) and development of new targeted drugs are leading to a new emphasis on drug combination experiments. Many studies continue to use the median-effect method of Chou–Talalay ([2][2]). However, the median-effect method follows a similar logic to Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ashton, J. C. (2015). Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter. Cancer Research, 75(11), 2400. https://doi.org/10.1158/0008-5472.can-14-3763

MLA 9

Ashton, John C. “Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter.” Cancer Research, vol. 75, no. 11, 2015, p. 2400. https://doi.org/10.1158/0008-5472.can-14-3763.

Chicago

Ashton, John C. 2015. “Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter.” Cancer Research 75 (11): 2400. https://doi.org/10.1158/0008-5472.can-14-3763.

Harvard

Ashton, J. C. (2015) ‘Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter’, Cancer Research, 75(11), p. 2400. doi:10.1158/0008-5472.can-14-3763.

IEEE

J. C. Ashton, “Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter,” Cancer Research, vol. 75, no. 11, p. 2400, 2015, doi: 10.1158/0008-5472.can-14-3763.

BibTeX

@article{ashton2015drug,
  title     = {{Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter}},
  author    = {Ashton, John C.},
  journal   = {Cancer Research},
  year      = {2015},
  volume    = {75},
  number    = {11},
  pages     = {2400},
  doi       = {10.1158/0008-5472.can-14-3763},
  url       = {https://doi.org/10.1158/0008-5472.can-14-3763}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201799
201899
20191616
20202121
20212323
20222020
20231414
20242121
20251616
20261313

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • Chou-Talalay method
  • combination therapy
  • drug synergy

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Ashton, J. C. (2015). Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter. Cancer Research, 75(11), 2400. https://doi.org/10.1158/0008-5472.can-14-3763

How many times has this paper been cited?

176 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

John C. Ashton.

What is the DOI of this paper?

10.1158/0008-5472.can-14-3763. The permanent link is https://doi.org/10.1158/0008-5472.can-14-3763.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.